In Vivo Intracellular Oxygen Dynamics in Murine Brain Glioma and Immunotherapeutic Response of Cytotoxic T Cells Observed by Fluorine-19 Magnetic Resonance Imaging

por Zhong, Jia, Sakaki, Masashi, Okada, Hideho, Ahrens, Eric T.
Publicado 2013

Immune-Checkpoint Blockade and Active Immunotherapy for Glioma

por Ahn, Brian J., Pollack, Ian F., Okada, Hideho
Publicado 2013

ONO-AE3-208 inhibits myeloid derived suppressor cells and glioma growth

por Kohanbash, Gary, Straw , Erin, Ahn, Brian, Okada, Hideho
Publicado 2014

Immunotherapy Approaches in Isocitrate-Dehydrogenase-Mutant Low-Grade Glioma

por Gallus, Marco, Kwok, Darwin, Lakshmanachetty, Senthilnath, Yamamichi, Akane, Okada, Hideho
Publicado 2023

Glioma immunoediting, a driver of tumor evolution, and the next battle for immunotherapy

por Sonabend, Adam M., Stupp, Roger, Lee-Chang, Catalina, Okada, Hideho
Publicado 2021

Current Advances in Immunotherapy for Glioblastoma

por Mende, Abigail L., Schulte, Jessica D., Okada, Hideho, Clarke, Jennifer L.
Publicado 2021

IFN-γ- and IL-17-producing CD8(+) T (Tc17-1) cells in combination with poly-ICLC and peptide vaccine exhibit antiglioma activity

por Ohkuri, Takayuki, Kosaka, Akemi, Ikeura, Maki, Salazar, Andres M, Okada, Hideho
Publicado 2021

IDH mutation-induced suppression of type-1 anti-glioma immune response

por Kohanbash, Gary, Shrivastav, Shruti, Ahn, Brian, Hou, Yafei, Costello, Joseph, Okada, Hideho
Publicado 2015

Genetically Engineered T-Cells for Malignant Glioma: Overcoming the Barriers to Effective Immunotherapy

por Chuntova, Pavlina, Downey, Kira M., Hegde, Bindu, Almeida, Neil D., Okada, Hideho
Publicado 2019

Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Immisch et al

por Chheda, Zinal S, Mueller, Sabine, Hegde, Bindu, Yamamichi, Akane, Butterfield, Lisa H, Okada, Hideho
Publicado 2023

Fluorine-19 nuclear magnetic resonance of chimeric antigen receptor T cell biodistribution in murine cancer model

por Chapelin, Fanny, Gao, Shang, Okada, Hideho, Weber, Thomas G., Messer, Karen, Ahrens, Eric T.
Publicado 2017

Expression of miR-17-92 enhances anti-tumor activity of T-cells transduced with the anti-EGFRvIII chimeric antigen receptor in mice bearing human GBM xenografts

por Ohno, Masasuke, Ohkuri, Takayuki, Kosaka, Akemi, Tanahashi, Kuniaki, June, Carl H, Natsume, Atsushi, Okada, Hideho
Publicado 2013

Workshop on immunotherapy combinations. Society for immunotherapy of cancer annual meeting Bethesda, November 3, 2011

por Forero, Ivan Martinez, Okada, Hideho, Topalian, Suzanne L, Gajewski, Thomas F, Korman, Alan J, Melero, Ignacio
Publicado 2012

Detection of inflammatory cell function using (13)C magnetic resonance spectroscopy of hyperpolarized [6-(13)C]-arginine

por Najac, Chloé, Chaumeil, Myriam M., Kohanbash, Gary, Guglielmetti, Caroline, Gordon, Jeremy W., Okada, Hideho, Ronen, Sabrina M.
Publicado 2016

IMMU-14. SynNotch chimeric antigen receptor (CAR) T-cells as a potential treatment for diffuse intrinsic pontine glioma (DIPG)/diffuse midline glioma (DMG)

por Ferrerosa, Lauren, Simic, Milos, Watchmaker, Payal, Diebold, David, Pineo-Cavanaugh, Psalm, Deucker, Jason, Lim, Wendall, Okada, Hideho
Publicado 2022

Spontaneous immune responses against glioma-associated antigens in a long term survivor with malignant glioma

por Ueda, Ryo, Low, Keri L, Zhu, Xinmei, Fujita, Mitsugu, Sasaki, Kotaro, Whiteside, Theresa L, Butterfield, Lisa H, Okada, Hideho
Publicado 2007

Promise and challenges of peptide-poly: ICLC vaccines for adult and pediatric gliomas

por Okada, Hideho, Butterfield, Lisa H, Hamilton, Ronald L, Salazar, Andres M, Potter, Douglas M, Lieberman, Frank S, Pollack, Ian F
Publicado 2013

Vaccination with EphA2-derived T cell-epitopes promotes immunity against both EphA2-expressing and EphA2-negative tumors

por Hatano, Manabu, Kuwashima, Naruo, Tatsumi, Tomohide, Dusak, Jill E, Nishimura, Fumihiko, Reilly, Karlyne M, Storkus, Walter J, Okada, Hideho
Publicado 2004

Differential activity of interferon-α8 promoter is regulated by Oct-1 and a SNP that dictates prognosis of glioma

por Kohanbash, Gary, Ishikawa, Eiichi, Fujita, Mitsugu, Ikeura, Maki, McKaveney, Kayla, Zhu, Jianzhong, Sakaki, Masashi, Sarkar, Saumendra N., Okada, Hideho
Publicado 2012

STING contributes to anti-glioma immunity via triggering type-I IFN signals in the tumor microenvironment

por Ohkuri, Takayuki, Ghosh, Arundhati, Kosaka, Akemi, Zhu, Jianzhong, Ikeura, Maki, David, Michael, Watkins, Simon C, Sarkar, Saumendra N, Okada, Hideho
Publicado 2014